Literature DB >> 32515882

Occupational health responses to COVID-19: What lessons can we learn from SARS?

David Koh1,2, Hui Poh Goh1.   

Abstract

On 31 December 2019, the World Health Organization (WHO) received reports of pneumonia cases of unknown etiology in the city of Wuhan in Hubei Province, China. The agent responsible was subsequently identified as a coronavirus-SARS-CoV-2. The WHO declared this disease as a Public Health Emergency of International Concern at the end of January 2020. This event evoked a sense of déjà vu, as it has many similarities to the outbreak of severe acute respiratory syndrome (SARS) of 2002-2003. Both illnesses were caused by a zoonotic novel coronavirus, both originated during winter in China and both spread rapidly all over the world. However, the case-fatality rate of SARS (9.6%) is higher than that of COVID-19 (<4%). Another zoonotic novel coronavirus, MERS-CoV, was responsible for the Middle East respiratory syndrome, which had a case-fatality rate of 34%. Our experiences in coping with the previous coronavirus outbreaks have better equipped us to face the challenges posed by COVID-19, especially in the health care setting. Among the insights gained from the past outbreaks were: outbreaks caused by viruses are hazardous to healthcare workers; the impact of the disease extends beyond the infection; general principles of prevention and control are effective in containing the disease; the disease poses both a public health as well as an occupational health threat; and emerging infectious diseases pose a continuing threat to the world. Given the perspectives gained and lessons learnt from these past events, we should be better prepared to face the current COVID-19 outbreak.
© 2020 The Authors. Journal of Occupational Health published by John Wiley & Sons Australia, Ltd on behalf of The Japan Society for Occupational Health.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; coronavirus; health care; occupational health; outbreaks; public health

Mesh:

Year:  2020        PMID: 32515882      PMCID: PMC7221300          DOI: 10.1002/1348-9585.12128

Source DB:  PubMed          Journal:  J Occup Health        ISSN: 1341-9145            Impact factor:   2.708


On 31 December 2019, the World Health Organization (WHO) was informed of pneumonia cases of unknown etiology detected in Wuhan city in Hubei Province, central China. By 9 January 2020, WHO released a statement on the cluster of cases, which stated that “Chinese authorities have made a preliminary determination of a novel coronavirus, identified in a hospitalized person with pneumonia in Wuhan”. The virus was initially referred to as 2019‐nCoV, but has since been re‐named as SARS‐CoV‐2 on 12 February 2020. The WHO declared this disease, COVID‐19 as a Public Health Emergency of International Concern at the end of January 2020. In a span of less than 2 months, there have been over 70,000 confirmed cases and over 1800 deaths due to the infection. By early April 2020, there were over 1.1 million confirmed cases and over 62 000 deaths spread over 200 countries and territories. Initial reports suggested that the overall case‐fatality of COVID‐19 infection appeared to be approximately 2%. The case‐fatality was much higher in the city of Wuhan (currently around 4.9%) as compared to other parts of China and the rest of the world. The disease has an estimated mean incubation period of 5.2 days (95% CI 4.1‐7.0) and a basic reproductive number (Ro) of 2.2 (95% CI 1.4‐3.9). It is possible that people with COVID‐19 may be infectious even before showing significant symptoms. However, it is believed that those who have symptoms are the ones who are primarily causing the spread of the infection. These figures have been updated recently, with an estimated Ro of between 2.0 and 2.5 for SARS‐CoV‐2, incubation period of 1‐14 days (mean 5‐6) days and a mortality rate of about 3.8%, based on a larger sample of 55 924 cases. This event evoked a strong sense of déjà vu, as it has many parallels to the outbreak of SARS during 2002 and 2003. Similar to COVID‐19, SARS originated during winter in China, spread rapidly all over the world affecting 37 countries, and was caused by a zoonotic novel coronavirus. However, in comparison, SARS affected far fewer people (8098 reported cases) but had a higher case‐fatality rate of 9.6% (774 deaths). Another zoonotic novel coronavirus, MERS‐CoV, originated in the Middle East in 2012. In all, there have been 2494 reported MERS‐CoV cases resulting in 858 deaths (case‐fatality rate, 34%) in 27 countries. Outbreaks of MERS have been reported in hospitals in countries such as Saudi Arabia, Jordan, and South Korea. Our experiences in coping with the previous SARS and MERS outbreaks have better prepared us to face the new challenge posed by COVID‐19. In particular, we learnt many valuable lessons from dealing with the SARS outbreak, which was an unprecedented event. The perspectives and experiences gained from managing SARS, and comparisons to our responses to the COVID‐19 outbreak include the following:

RECOGNITION THAT WORKING IN HEALTH CARE SETTINGS CAN BE HAZARDOUS TO HEALTH

Healthcare workers (HCWs) in health care establishments include doctors, nurses, laboratory and paramedical staff, health attendants and cleaners. Other than health care workers, anyone who are physically present or associated with health care institutions were at high risk of infection by SARS‐CoV. Worldwide, HCWs comprised a significant 21% of all SARS patients, but in countries such as Canada and Singapore, more than 40% of the patients were HCWs. Performance of certain procedures, such as intubation and nebulization of SARS patients was recognized as having a significant risk of infection. However, even low‐exposure situations and transient exposures to infected cases posed infection risks. There were also reports of “super‐spreaders,” who often were initially undiagnosed, and who spread the disease to clusters of HCWs. Healthcare workers are also a recognized high‐risk exposure group to SARS‐CoV‐2. As of 2 March 2020, more than 3400 HCWs have been infected in China, with 13 deaths reported. A COVID‐19 “super‐spreader” was reported in a Wuhan hospital. The patient presented with abdominal symptoms and was initially admitted to a surgery department, resulting in over 10 HCWs being infected. In many other countries, currently thousands of HCWs have been infected, and hundreds have died, though not all have occurred because of occupational exposure. This is because household and community transmission have also played a role in the infection of HCWs. In general, HCWs are now better equipped and better trained and prepared with infection control techniques as compared to the time of SARS. The number of HCWs as a proportion of all cases of COVID‐19 appears to be smaller and HCWs comprise less than 20% of cases. Several factors may have contributed to this. For example, in Singapore, there are established occupational medicine departments to protect HCWs in major Singapore government hospitals in 2020. In comparison, no such departments existed in 2003. To reduce the risk of occupational exposure to infection, personal protective equipment (PPE) have been stockpiled, HCWs are mask fitted, repeated training in infection control techniques have been given, and strict adherence to infection control protocols is mandated. There is also extensive daily monitoring of health among staff. World Health Organization has developed several technical guidance documents regarding COVID‐19 for HCWs, including rights, roles and responsibilities of HCWs which comprises key considerations for safety and health. As part of a WHO preparedness and response initiative, they have also established a risk assessment tool that is to be used by health care facilities to determine the risk of SARS‐CoV‐2 infection of all HCWs who have been exposed to a COVID‐19 patient. This tool also provides recommendations for appropriate management of these HCWs, according to their infection risk. However, the magnitude of the pandemic, with its explosive increase in number of infected patients requiring treatment in health care facilities, has resulted in health care establishments being overwhelmed in many countries. There are shortages of PPE such as N95 masks and surgical masks for health care workers, and ventilators for patients even in the more developed countries with robust health care systems. There has also been a profound loss of trust in authority with perceptions that policy is guided more by scarcity than science. In the developing countries, the situation is even more dire.

THE IMPACT OF THE DISEASE EXTENDS BEYOND THE INFECTION

During the SARS outbreak, HCWs in affected countries worked under great stress and in constant fear. Besides being exposed to the virus, they experienced fatigue, burnout, stigma and were at risk for physical and psychological violence. The need to protect themselves by having to wear uncomfortable PPE at all times, the necessity to monitor body temperature several times a day, enforced restriction of movements within and between health care establishments and having to work long hours in physically separate teams were common features of health care work. About a third (29%‐35%) of hospital workers in Toronto experienced a high degree of distress, as measured on the Impact of Event Scale. In Singapore, over ten thousand HCWs in nine health care settings were surveyed during the SARS outbreak. Many reported feeling more stressed at work, experiencing an increase in workload and having to work overtime. Most respondents agreed that “people close to me are worried for my health,” and that “people close to me are worried they might get infected through me.” In addition, there was also fear and stigmatization of HCWs and their family members from the public because of their occupation. (Table 1).
TABLE 1

Responses of Healthcare workers in Singapore during the SARS outbreak, 2003 (n = 10 511)

I feel more stressed at work56%
I experienced an increase in workload53%
I have to perform work that I normally don't do54%
I had to work overtime36%
People close to me are worried for my health87%
People close to me are worried they might get infected through me69%
People avoid me because of my job49%
People avoid my family members because of my job31%

Source: Koh et al. (2005) .

Responses of Healthcare workers in Singapore during the SARS outbreak, 2003 (n = 10 511) Source: Koh et al. (2005) . During this COVID‐19 outbreak, HCWs are similarly working under extreme conditions over long hours. Many HCWs have fears for their personal health and many have their family members worried for them. The need for management of stress and fatigue among HCWs is important and should be recognized and provided for. At the same time, stigmatization and ostracization of HCWs have been witnessed. Due to their occupation, HCWs are shunned and harassed by some members of a fearful public. These reactions arise largely from ignorance and anxiety. Such adverse reactions have also been directed towards other groups of people, such as those under quarantine, or persons of specific races and nationalities. The CDC has identified persons of Asian descent, people who have travelled and emergency responders or healthcare professionals as groups who may be at risk of being stigmatized. On the other hand, there have are also been positive reactions from the public and strong expressions of gratitude and support for HCWs. Many members of the public do appreciate the HCWs’ dedication to work and the sacrifices they make and there has been a general outpouring of support from the public for HCWs in many countries. Besides the obvious stressors of working long hours under conditions of risk of infections, and separation from their families and loved ones another mental health challenge faced by health care workers is the dilemma they face when deciding how to ration scarce health care resources to patients. In countries such as Italy, where the number of patients who need ventilators outnumbered the available equipment, health care workers were forced to make uncomfortable life or death decisions. The lack of resources contributed in part, to the high COVID‐19 death rate in Italy. This is unfortunately another challenge seen in COVID‐19 outbreak that was not encountered during the SARS outbreak. Mental health support for HCWs can be provided via multidisciplinary mental health teams, which include psychiatrists, psychiatric nurses, clinical psychologists, and other mental health workers. Regular, accurate and clear communication updates should be provided in order to allay prevailing uncertainty and fear that the HCWs are experiencing. HCWs caring for COVID‐19 patients may also require regular clinical screening for depression and anxiety. However, specific mental health issues may need to be managed by different approaches. For example, one possible solution to help clinicians directly involved in managing critically ill patients from making ethically difficult choices such as deciding who receives ventilator care, is to form a triage committee. Such a committee can comprise volunteers, including respected clinicians and leaders, among their peers. The committee can be tasked to make these difficult choices, in order to spare the frontline clinicians from the dilemma of rationing scarce medical resources.

GENERAL PRINCIPLES OF PREVENTION AND CONTROL ARE EFFECTIVE IN CONTAINING THE DISEASE

Severe acute respiratory syndrome was spread to HCWs mainly by direct mucous membrane contact with infectious respiratory droplets and exposure to contaminated surfaces. Prevention and control measures were early detection and isolation of cases and quarantine of exposed members of the public. These measures were effective. For example, secondary cases of SARS were minimal when the source cases were isolated within 2 days of onset of symptoms. However, if isolation was delayed, the number of secondary cases increased rapidly. For HCWs, effective preventive measures involve wearing of gloves, gowns, eye protection, N95 masks, practising good personal hygiene, and self‐monitoring for early disease symptoms and early treatment. Although the implementation of such measures on a massive scale was initially challenging, most health systems and HCWs eventually coped. However, sustaining such extensive preventive measures over prolonged periods was difficult. For the COVID‐19 outbreak, we have witnessed extensive contact tracing and quarantine measures implemented in major Chinese cities, affecting millions of people. Implementing such measures requires advance planning of suitable locations for quarantine, giving support to patients who are in quarantine and being strict to those who break the laws by enforcing penalties. Health care resources have also been marshalled and mobilized on an unprecedented scale to respond to those who require treatment. However, a current challenge is the worldwide shortage of medical supplies such as PPE and medical equipment such as ventilators, and even test kits for diagnosis. Advice given for the general public for COVID‐19 has seen a greater emphasis placed on hand washing, personal hygiene (such as not touching the face with contaminated hands), respiratory hygiene (eg, practising cough etiquette by coughing or sneezing away from others or into the sleeves and wearing masks if feeling unwell), social distancing, avoidance of crowds, travel advice and advice that persons who are well need not wear masks. Due to the limited supply of masks, the initial general advice has been for masks to be worn by ill patients and people who have close contact or who are looking after ill patients. For the general public, information on types of masks to wear (surgical masks would suffice, rather than N95 masks), the proper way of wearing and disposing of masks in a safe and socially responsible manner has been given. However, it is important to note that such information continues to evolve. The latest guidelines from Centers for Disease Control and Prevention (CDC) in April 2020 recommend that masks or face coverings should be worn by the public when they go out. One reason for the change in advice is the recognition that there may be asymptomatic cases who might spread infected respiratory droplets to other members of the public if they are not wearing face coverings or masks. Social distancing has been implemented as part of the efforts to “flatten the curve”. The “curve” refers to the projected number of people who will contract COVID‐19 over a period of time. By implementing community isolation measures, the daily number of disease cases can be kept at a manageable level for medical providers, hence it may help lessen the healthcare burden. As the situation evolves, some countries are employing more restrictive measures such as travel bans and lockdowns. It was reported that by the end of March 2020, more than 100 countries had instituted either a full or partial lockdown, impacting billions of residents.

THE DISEASE POSES BOTH A PUBLIC HEALTH AS WELL AS AN OCCUPATIONAL HEALTH THREAT

Severe acute respiratory syndrome was widely viewed as a public health threat but was less appreciated as an occupational disease. Among the occupational groups at risk were HCWs, animal and food preparation handlers, transport workers (ranging from flight attendants to taxi drivers), and laboratory researchers working with the SARS‐CoV. For example, more than a third of the early cases of SARS (pre‐February 2003) occurred in persons who handled, killed, or sold food animals, or in those who prepared or served food. Thus, in addition to public health measures, an appropriate occupational health response is also necessary. In the current COVID‐19 outbreak, diverse occupational groups are recognized to be at risk. For example, in Singapore, 68% of the first 25 locally transmitted cases were probably related to occupational exposure. The workers who are in the hospitality, retail, food and beverage industry who served infected tourists, transport workers, multinational company workers who attended an international meeting, a domestic worker and even a security officer who served quarantine orders were all at risk. These occupations were not covered by the occupational health legislation of Singapore in 2003, which was the Factories Act. However, in 2020, the Workplace Safety and Health Act in Singapore applies to many of these workers. Thus, if and when the disease is officially recognized as an occupational disease, these workers (and not only factory workers) will be covered by the health and safety law. A major concern of many workers is the fear of job losses or loss of income. This is apparent from the economic impact of COVID‐19 where in many countries, non‐essential services have been halted, and many people stay at home and avoid going out for shopping or entertainment. Self‐employed workers, workers in a gig economy, and those working in entertainment, hospitality, tourism and travel sectors, to name a few, will be threatened with loss of income and job losses. In order to manage the economic fallout, many governments have provided stimulus packages to assist such groups. Companies and occupational health departments may also play a role in the national and international pandemic response and in managing such concerns among workers under their care.

EMERGING INFECTIOUS DISEASES WILL POSE A CONTINUING THREAT TO THE WORLD

Since August 2003, after the containment of SARS, new diseases have periodically surfaced to confront the world on a regular basis. These include the appearance of viruses eg, MERS‐CoV, various influenza viruses eg, H1N1 (Swine flu), H5N1 (Avian influenza), H7N9, Zika virus, and the deadly Ebola virus. Such ongoing and sporadic events remind us that it is a certainty that emerging infections will continue to remain as real threats to our world, and we should be ever vigilant and ready to respond.
  14 in total

1.  Lessons from the past: perspectives on severe acute respiratory syndrome.

Authors:  David Koh; J Sng
Journal:  Asia Pac J Public Health       Date:  2010-07       Impact factor: 1.399

2.  Managing mental health challenges faced by healthcare workers during covid-19 pandemic.

Authors:  Neil Greenberg; Mary Docherty; Sam Gnanapragasam; Simon Wessely
Journal:  BMJ       Date:  2020-03-26

3.  Critical Supply Shortages - The Need for Ventilators and Personal Protective Equipment during the Covid-19 Pandemic.

Authors:  Megan L Ranney; Valerie Griffeth; Ashish K Jha
Journal:  N Engl J Med       Date:  2020-03-25       Impact factor: 91.245

4.  Preparation for Possible Sustained Transmission of 2019 Novel Coronavirus: Lessons From Previous Epidemics.

Authors:  David L Swerdlow; Lyn Finelli
Journal:  JAMA       Date:  2020-03-24       Impact factor: 56.272

5.  Coronavirus covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate.

Authors:  Elisabeth Mahase
Journal:  BMJ       Date:  2020-02-18

6.  Risk perception and impact of Severe Acute Respiratory Syndrome (SARS) on work and personal lives of healthcare workers in Singapore: what can we learn?

Authors:  David Koh; Meng Kin Lim; Sin Eng Chia; Soo Meng Ko; Feng Qian; Vivian Ng; Ban Hock Tan; Kok Seng Wong; Wuen Ming Chew; Hui Kheng Tang; Winston Ng; Zainal Muttakin; Shanta Emmanuel; Ngan Phoon Fong; Gerald Koh; Chong Teck Kwa; Keson Beng-Choon Tan; Calvin Fones
Journal:  Med Care       Date:  2005-07       Impact factor: 2.983

7.  The experience of the 2003 SARS outbreak as a traumatic stress among frontline healthcare workers in Toronto: lessons learned.

Authors:  Robert Maunder
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2004-07-29       Impact factor: 6.237

8.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.

Authors:  Qun Li; Xuhua Guan; Peng Wu; Xiaoye Wang; Lei Zhou; Yeqing Tong; Ruiqi Ren; Kathy S M Leung; Eric H Y Lau; Jessica Y Wong; Xuesen Xing; Nijuan Xiang; Yang Wu; Chao Li; Qi Chen; Dan Li; Tian Liu; Jing Zhao; Man Liu; Wenxiao Tu; Chuding Chen; Lianmei Jin; Rui Yang; Qi Wang; Suhua Zhou; Rui Wang; Hui Liu; Yinbo Luo; Yuan Liu; Ge Shao; Huan Li; Zhongfa Tao; Yang Yang; Zhiqiang Deng; Boxi Liu; Zhitao Ma; Yanping Zhang; Guoqing Shi; Tommy T Y Lam; Joseph T Wu; George F Gao; Benjamin J Cowling; Bo Yang; Gabriel M Leung; Zijian Feng
Journal:  N Engl J Med       Date:  2020-01-29       Impact factor: 176.079

9.  Occupational risks for COVID-19 infection.

Authors:  David Koh
Journal:  Occup Med (Lond)       Date:  2020-03-12       Impact factor: 1.611

10.  Preventing Intra-hospital Infection and Transmission of Coronavirus Disease 2019 in Health-care Workers.

Authors:  Wee Hoe Gan; John Wah Lim; David Koh
Journal:  Saf Health Work       Date:  2020-03-24
View more
  21 in total

1.  Double Face Mask Use for COVID-19 Infection Prevention and Control Among Medical Students at Makerere University: A Cross-Section Survey.

Authors:  Racheal Nalunkuma; Derrick Bary Abila; Nelson Ssewante; Blaise Kiyimba; Edwin Kigozi; Ruth Ketty Kisuza; Fulugensio Kasekende; Jonathan Nkalubo; Samuel Kalungi; Winters Muttamba; Sarah Kiguli
Journal:  Risk Manag Healthc Policy       Date:  2022-01-20

2.  COVID-19 infection across workplace settings in Qatar: a comparison of COVID-19 positivity rates of screened workers from March 1st until July 31st, 2020.

Authors:  Mohamed Ghaith Al-Kuwari; Asma Ali Al-Nuaimi; Jazeel Abdulmajeed; Sandy Semaan; Hamad Eid Al-Romaihi; Mujeeb Chettiyam Kandy; Selvakumar Swamy
Journal:  J Occup Med Toxicol       Date:  2021-06-17       Impact factor: 2.646

3.  Predictive Factors Associated With Fear Faced by Healthcare Workers During COVID-19 Pandemic: A Questionnaire-Based Study.

Authors:  Jagdesh Kumar; Muhammad Soughat Katto; Adeel A Siddiqui; Badaruddin Sahito; Bashir Ahmed; Muhammad Jamil; Maratib Ali
Journal:  Cureus       Date:  2020-08-14

4.  Countermeasures against COVID-19: how to navigate medical practice through a nascent, evolving evidence base - a European multicentre mixed methods study.

Authors:  Fabian Eibensteiner; Valentin Ritschl; Tanja Stamm; Asil Cetin; Claus Peter Schmitt; Gema Ariceta; Sevcan Bakkaloglu; Augustina Jankauskiene; Günter Klaus; Fabio Paglialonga; Alberto Edefonti; Bruno Ranchin; Rukshana Shroff; Constantinos J Stefanidis; Johan Vandewalle; Enrico Verrina; Karel Vondrak; Aleksandra Zurowska; Seth L Alper; Christoph Aufricht
Journal:  BMJ Open       Date:  2021-02-17       Impact factor: 2.692

5.  Chasing the ghost of infection past: identifying thresholds of change during the COVID-19 infection in Spain.

Authors:  Luis Santamaría; Joaquín Hortal
Journal:  Epidemiol Infect       Date:  2020-11-13       Impact factor: 2.451

6.  Occupational Health and Safety Measures in German Outpatient Care Services during the COVID-19 Pandemic: A Qualitative Study.

Authors:  Mara Shirin Hetzmann; Natascha Mojtahedzadeh; Albert Nienhaus; Volker Harth; Stefanie Mache
Journal:  Int J Environ Res Public Health       Date:  2021-03-14       Impact factor: 3.390

7.  Personal protective equipment guidance during a global pandemic: A statistical analysis of National perceived confidence, knowledge and educational deficits amongst UK-based doctors.

Authors:  Shams Al-Hity; Navdeep Bhamra; Ravi Kumar; Keshav Kumar Gupta; James Howard; Karan Jolly; Adnan Darr
Journal:  Int J Clin Pract       Date:  2021-01-27       Impact factor: 3.149

8.  Long working hours and burnout in health care workers: Non-linear dose-response relationship and the effect mediated by sleeping hours-A cross-sectional study.

Authors:  Ro-Ting Lin; Yu-Ting Lin; Ying-Fang Hsia; Chin-Chi Kuo
Journal:  J Occup Health       Date:  2021-01       Impact factor: 2.708

9.  COVID-19 infection across workplace settings in Qatar: a comparison of COVID-19 positivity rates of screened workers from March 1st until July 31st, 2020.

Authors:  Mohamed Ghaith Al-Kuwari; Asma Ali Al-Nuaimi; Jazeel Abdulmajeed; Sandy Semaan; Hamad Eid Al-Romaihi; Mujeeb Chettiyam Kandy; Selvakumar Swamy
Journal:  J Occup Med Toxicol       Date:  2021-06-17       Impact factor: 2.646

10.  Symptoms in Health Care Workers during the COVID-19 Epidemic. A Cross-Sectional Survey.

Authors:  Nicola Magnavita; Giovanni Tripepi; Reparata Rosa Di Prinzio
Journal:  Int J Environ Res Public Health       Date:  2020-07-20       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.